Efficacy Testing of Melon Oil Olive Pressed Candy Products
1 other identifier
interventional
60
1 country
1
Brief Summary
To assess melon and oil olive pressed candy on skin condition improvement
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 9, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedFirst Submitted
Initial submission to the registry
August 4, 2023
CompletedFirst Posted
Study publicly available on registry
August 14, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFebruary 21, 2024
February 1, 2024
23 days
August 4, 2023
February 19, 2024
Conditions
Outcome Measures
Primary Outcomes (10)
The change of skin wrinkles
VISIA Complexion Analysis System was utilized to measure skin wrinkles. Units: arbitrary units
Change from Baseline skin wrinkles at 12 weeks
The change of skin texture
VISIA Complexion Analysis System was utilized to measure skin texture. Units: arbitrary units
Change from Baseline skin texture at 12 weeks
The change of skin melanin index
Mexameter® MX18 was utilized to measure skin melanin index. Units: arbitrary units
Change from Baseline skin melanin index at 12 weeks
The change of skin erythema index
Mexameter® MX18 was utilized to measure skin erythema index. Units: arbitrary units
Change from Baseline skin erythema index at 12 weeks
The change of skin L* value
Chroma Meter MM500 was utilized to measure skin L\* value. Units: arbitrary units
Change from Baseline L* value at 12 weeks
The change of skin b* value
Chroma Meter MM500 was utilized to measure skin b\* value. Units: arbitrary units
Change from Baseline b* value at 12 weeks
The change of skin ITA° value
Chroma Meter MM500 was utilized to measure skin ITA° value. Units: arbitrary units
Change from Baseline ITA° value at 12 weeks
The change of skin spots
VISIA Complexion Analysis System was utilized to measure skin spots. Units: arbitrary units
Change from Baseline skin spots at 12 weeks
The change of skin UV spots
VISIA Complexion Analysis System was utilized to measure skin UV spots. Units: arbitrary units
Change from Baseline skin UV spots at 12 weeks
The change of skin brown spots
VISIA Complexion Analysis System was utilized to measure skin brown spots. Units: arbitrary units
Change from Baseline skin brown spots at 12 weeks
Secondary Outcomes (3)
The change of TEAC of blood
Change from Baseline TEAC at 12 weeks
The change of SOD of blood
Change from Baseline SOD at 12 weeks
The change of GSH-Px of blood
Change from Baseline GSH-Px at 12 weeks
Other Outcomes (1)
The change of self-assessment skin and hair condition
Change from Baseline skin and hair condition at 12 weeks
Study Arms (2)
Placebo candy
PLACEBO COMPARATORmelon and oil olive pressed candy
EXPERIMENTALInterventions
consume 2 tablets per day
Eligibility Criteria
You may qualify if:
- Healthy adults aged above 18 years old
- ITA° value 20°-41°
You may not qualify if:
- Involuntary subjects.
- Subjects who have a history of skin diseases such as psoriasis, eczema, atopic dermatitis, severe acne; or suffer from other chronic systemic disease.
- Those with known cosmetic, drug or food allergies.
- Female who is pregnant or nursing or planning to become pregnant during the course of the study.
- Subjects who have taken oral or topical corticosteroids and other anti-inflammatory drugs in the past 1 month.
- Use of any products or drugs that affect skin color such as fruit acid, salicylic acid (such as Hydroquinone preparations) in the past 2 months.
- In the past 3 months, the test site has used retinoic acid preparations or undergone chemical peeling, laser, pulse light and other medical aesthetic therapists
- Subjects who can not avoid long-term sun exposure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- TCI Co., Ltd.lead
Study Sites (1)
Chia Nan University of Pharmacy & Science
Tainan, Taiwan
Related Publications (1)
He Y, Bu Y, Chiang CF, Lin YH, Liang CH, Chan LP, Sun J. Multi-Plant Concentrated Powder Improved Skin Whitening: A Double-Blinded, Randomized, and Placebo-Controlled Clinical Study. J Cosmet Dermatol. 2025 Feb;24(2):e70011. doi: 10.1111/jocd.70011.
PMID: 39927597DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chia-Hua Liang, Prof.
Chia Nan University of Pharmacy & Science
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 4, 2023
First Posted
August 14, 2023
Study Start
May 9, 2023
Primary Completion
June 1, 2023
Study Completion
December 31, 2023
Last Updated
February 21, 2024
Record last verified: 2024-02